EIP
AGN

Ellis Investment Partners’s Allergan plc AGN Stock Holding History

Ellis Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-449
Closed -$78K – 775
2020
Q1 		$78K Buy
449
+1
+0.2% +$188 0.04% 230
2019
Q4 		$86K Buy
448
+2
+0.4% +$361 0.03% 258
2019
Q3 		$74K Sell
446
-20
-4% -$3.26K 0.03% 277
2019
Q2 		$78K Sell
466
-5,162
-92% -$715K 0.03% 270
2019
Q1 		$831K Sell
5,628
-289
-5% -$41.9K 0.34% 68
2018
Q4 		$790K Buy
+5,917
New +$970K 0.36% 62

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ellis Investment Partners's AGN Position: Q2 2020 in Review

Ellis Investment Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 449 shares — an estimated $78K sold.

Ellis Investment Partners first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $831K in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ellis Investment Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ellis Investment Partners sold 449 Allergan plc shares in Q2 2020, an estimated $78K.
  • Ellis Investment Partners first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Ellis Investment Partners's Allergan plc position peaked at $831K in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ellis Investment Partners's 13F filing for Q2 2020, filed 13 Jul 2020.